Every one of those 1 sits in a single category, renewable-energy. Amprius Technologies is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Keros Therapeutics appears in 1 tracked Climate story from March 4, 2026. The tracked stories average 2 original sources each.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Keros Therapeutics
Every one of those 1 sits in a single category, renewable-energy. Amprius Technologies is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Keros Therapeutics appears in 1 tracked Climate story from March 4, 2026. The tracked stories average 2 original sources each.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 17 Climate stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Keros Therapeutics. Shared-story counts are live from our verified record — not editorial picks.
Amprius Technologies reported its full-year 2025 financial results, highlighting a critical transition from pilot-scale production to industrial commercialization of its high-energy silicon anode batteries. The company is positioning its ultra-high-density storage solutions as the primary enabler for the burgeoning eVTOL and defense aviation sectors.
Keros Therapeutics is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.